Tumor necrosis factor receptor-associated factors (TRAFs) - PubMed (original) (raw)
Review
. 2001 Oct 1;20(44):6482-91.
doi: 10.1038/sj.onc.1204788.
Affiliations
- PMID: 11607847
- DOI: 10.1038/sj.onc.1204788
Review
Tumor necrosis factor receptor-associated factors (TRAFs)
J R Bradley et al. Oncogene. 2001.
Abstract
Tumor necrosis factor receptor-associated factors (TRAFS) were initially discovered as adaptor proteins that couple the tumor necrosis factor receptor family to signaling pathways. More recently they have also been shown to be signal transducers of Toll/interleukin-1 family members. Six members of the TRAF family have been identified. All TRAF proteins share a C-terminal homology region termed the TRAF domain that is capable of binding to the cytoplasmic domain of receptors, and to other TRAF proteins. In addition, TRAFs 2-6 have RING and zinc finger motifs that are important for signaling downstream events. TRAF proteins are thought to be important regulators of cell death and cellular responses to stress, and TRAF2, TRAF5 and TRAF6 have been demonstrated to mediate activation of NF-kappaB and JNK. TRAF proteins are expressed in normal and diseased tissue in a regulated fashion, suggesting that they play an important role in physiological and pathological processes.
Similar articles
- CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS, Miller HG, Everdeen DS, Dang TT, Crute JJ, Kehry MR. Pullen SS, et al. Biochemistry. 1998 Aug 25;37(34):11836-45. doi: 10.1021/bi981067q. Biochemistry. 1998. PMID: 9718306 - TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H. Hauer J, et al. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2874-9. doi: 10.1073/pnas.0500187102. Epub 2005 Feb 11. Proc Natl Acad Sci U S A. 2005. PMID: 15708970 Free PMC article. - High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS, Labadia ME, Ingraham RH, McWhirter SM, Everdeen DS, Alber T, Crute JJ, Kehry MR. Pullen SS, et al. Biochemistry. 1999 Aug 3;38(31):10168-77. doi: 10.1021/bi9909905. Biochemistry. 1999. PMID: 10433725 - Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.
Inoue Ji, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, Yamamoto T. Inoue Ji, et al. Exp Cell Res. 2000 Jan 10;254(1):14-24. doi: 10.1006/excr.1999.4733. Exp Cell Res. 2000. PMID: 10623461 Review. No abstract available. - TRAF-mediated regulation of immune and inflammatory responses.
Wang Y, Zhang P, Liu Y, Cheng G. Wang Y, et al. Sci China Life Sci. 2010 Feb;53(2):159-68. doi: 10.1007/s11427-010-0050-3. Epub 2010 Mar 7. Sci China Life Sci. 2010. PMID: 20596822 Review.
Cited by
- Ubiquitination and Metabolic Disease.
Ma M, Cao R, Tian Y, Fu X. Ma M, et al. Adv Exp Med Biol. 2024;1466:47-79. doi: 10.1007/978-981-97-7288-9_4. Adv Exp Med Biol. 2024. PMID: 39546135 Review. - Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis.
Xie L, Xue F, Cheng C, Sui W, Zhang J, Meng L, Lu Y, Xiong W, Bu P, Xu F, Yu X, Xi B, Zhong L, Yang J, Zhang C, Zhang Y. Xie L, et al. Signal Transduct Target Ther. 2024 Oct 16;9(1):273. doi: 10.1038/s41392-024-01977-z. Signal Transduct Target Ther. 2024. PMID: 39406701 Free PMC article. - Uncovering the Interaction between TRAF1 and MAVS in the RIG-I Pathway to Enhance the Upregulation of IRF1/ISG15 during Classical Swine Fever Virus Infection.
Zhang L, Tang R, Liang D, Wang W, Min K, Luo T, Li X. Zhang L, et al. Cells. 2024 Jul 8;13(13):1165. doi: 10.3390/cells13131165. Cells. 2024. PMID: 38995016 Free PMC article. - Pan-cancer analysis of the TRAF family genes and their correlation with prognosis, TME, immune and drug sensitivity.
Yao B, Hu W, Chen Y, Li J, Jiang K, Dou J. Yao B, et al. Eur J Med Res. 2024 Jun 2;29(1):307. doi: 10.1186/s40001-024-01875-8. Eur J Med Res. 2024. PMID: 38825674 Free PMC article. - TRAF1 from a Structural Perspective.
Jang H, Kim S, Kim DY, Han JH, Park HH. Jang H, et al. Biomolecules. 2024 Apr 23;14(5):510. doi: 10.3390/biom14050510. Biomolecules. 2024. PMID: 38785916 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials